INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $858,680 | +317929.6% | 46,315 | +89.5% | 0.06% | +243.8% |
| Q2 2023 | $270 | -100.0% | 24,437 | -68.3% | 0.02% | -77.5% |
| Q3 2022 | $1,074,000 | -4.4% | 76,984 | -5.3% | 0.07% | +1.4% |
| Q2 2022 | $1,123,000 | -36.7% | 81,333 | -25.4% | 0.07% | -25.5% |
| Q1 2022 | $1,773,000 | -3.9% | 108,984 | -3.8% | 0.09% | +3.3% |
| Q4 2021 | $1,845,000 | -9.1% | 113,248 | -17.2% | 0.09% | -15.0% |
| Q3 2021 | $2,030,000 | -27.8% | 136,720 | -2.9% | 0.11% | -28.7% |
| Q2 2021 | $2,811,000 | -9.9% | 140,758 | +4.1% | 0.15% | -20.2% |
| Q1 2021 | $3,121,000 | – | 135,214 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |